Small Molecule Inhibitors of Anthrax Toxin-induced Cytotoxicity Targeted Against Protective Antigen

Chemical Biology and Drug Design

Volumn 79, Issue 3, 2012, Pages 260-269

  Rubert Pérez, Charles ^a   López Pérez, Daneli ^a   Chmielewski, Jean ^a   Lipton, Mark ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Anthrax; Inhibitor; Protective antigen; Protein protein interaction

Indexed keywords

2'' [2 CARBAMOYLETHYL] 3' ISOPROPYL [1,1':4',1'' TERPHENYL] 3 CARBOXYLIC ACID; 2'' [2 CARBAMOYLVINYL] 3' ISOPROPYL [1,1':4',1'' TERPHENYL] 3 CARBOXYLIC ACID; ANTHRAX TOXIN; ANTIGEN; METHYL 2 (2 CARBAMOYLETHYL)BENZYLIDENE 3 METHYLBUTANOATE; METHYL 2 (2 IODOBENZYLIDENE) 3 METHYLBUTANOATE; METHYL 2 HYDROXY(2 IODOPHENYL)METHYL 3 METHYLBUTANOATE; METHYL 2 HYDROXY[2 (2 CARBAMOYLVINYL)PHENYL]METHYL 3 METHYLBUTANOATE; METHYL 2'' [2 CARBAMOYLVINYL] 3' ISOPROPYL [1,1':4',1'' TERPHENYL] 3 CARBOXYLATE; METHYL 2'' FORMYL 3' ISOPROPYL [1,1':4',1'' TERPHENYL] 3 CARBOXYLATE; METHYL 3' ISOPROPYL 4' (TRIFLUOROMETHYLSULFONYLOXY)BIPHENYL 3 CARBOXYLATE; METHYL 4' (TERT BUTYLDIMETHYLSILYLOXY) 3' ISOPROPYLBIPHENYL 3 CARBOXYLATE; N (3 CARBOXYPHENYL) 2 (2 CARBAMOYLETHYL)BENZYLIDENE 3 METHYLBUTANAMIDE; N (3 CARBOXYPHENYL) 2 (2 CARBAMOYLVINYL)BENZYLIDENE 3 METHYLBUTANAMIDE; N (3 ETHOXYCARBONYLPHENYL) 2 (2 CARBAMOYLETHYL)BENZYLIDENE 3 METHYLBUTANAMIDE; N (3 ETHOXYCARBONYLPHENYL) 2 (2 CARBAMOYLVINYL)BENZYLIDENE 3 METHYLBUTANAMIDE; N (3 ETHOXYCARBONYLPHENYL) 2 (2 IODOBENZYLIDENE) 3 METHYLBUTANAMIDE; O TERT BUTYLDIMETHYLSILYL 4 IODO 2 ISOPROPYLPHENOL; PROTECTIVE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG SYNTHESIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELLS, CULTURED; DRUG DESIGN; MACROPHAGES; MICE; PROTEIN INTERACTION MAPPING; SMALL MOLECULE LIBRARIES;

MURINAE;

EID: 84856039643     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01285.x     Document Type: Article

References (39)

1. Geny B., Popoff M.R. (2006) Bacterial proteins toxins and lipids: role in toxin targeting and activity. Biol Cell;98:633-651.
2. Binz T., Rummel A.. (2006) Recent advances in toxin receptors. In: Gillet D., Johannes L., editor. Recent Research Developments in Toxins from Bacteria and Other Organisms. Kerala, India: Research Signpost; p. 69-105.
3. Reig N., Van Der Goot F.G. (2006) About lipids and toxins. FEBS Lett;580:5572-5579.
4. Gilbert R.J.C. (2002) Pore-forming toxins. Cell Mol Life Sci;59:832-844.
5. Geny B., Popoff M.R. (2006) Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Biol Cell;98:667-678.
6. Hueck A.P., Tweten R.K., Johnson A.E. (2001) β-Barrel pore-forming toxins: intriguing dimorphic proteins. Biochemistry;40:9065-9073.
7. Parker M.W., Feil S.C. (2005) Pore-forming protein toxins: from structure to function. Prog Biophys Mol Biol;88:91-142.
8. Lacy D.B., Collier R.J. (2002) Structure and function of anthrax toxin. Curr Top Microbiol Immunol;271:61-85.
9. Bhatnagar R., Batra S. (2001) Anthrax toxin. Crit Rev Microbiol;27:167-200.
10. Bradley K.A., Mogridge J., Mourez M., Collier R.J., Young J.A. (2001) Identification of the cellular receptors for anthrax toxin. Nature;414:225-229.
11. Scobie H., Rainey G., Bradley K., Young J.A. (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A;100:5170-5174.
12. Wei W., Lu Q., Leppla S.H., Cohen S.N. (2006) The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell;124:1141-1154.
13. Gordon V.M., Klimpel K.R., Arora N., Hernderson M.A., Leppla S.H. (1995) Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun;63:82-87.
14. Milne J.C., Furlong D., Hanna P.C., Wall J.S., Collier R.J. (1994) Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem;269:20607-20612.
15. Lacy D.B., Mourez M., Fouassier A., Collier R.J. (2002) Mapping the anthrax protective antigen binding site on the lethal and edema factors. J Biol Chem;2277:3006-3010.
16. Mogridge J., Cunningham K., Collier R.J. (2002) Stoichiometry of anthrax toxin complexes. Biochemistry;41:1079-1082.
17. Beauregard K.E., Collier R.J., Swanson J.A. (2000) Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell Microbiol;2:251-258.
18. Singh Y., Klimpel K.R., Goel S., Swain P.K., Leppla S.H. (1999) Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect Immun;67:1853-1859.
19. Milne J.C., Collier R.J. (1993) pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol Microbiol;10:647-653.
20. Kirby J.E. (2004) Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun;72:430-439.
21. Hanna P.C., Kochi S., Collier R.J. (1992) Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell;3:1269-1277.
22. Hanna P.C., Kruskal B.A., Ezekowitz R.A., Bloom B.R., Collier R.J. (1994) Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med;1:7-18.
23. Young J.A.T., Collier R.J. (2007) Anthrax toxin: receptor binding, internalization, pore formation, translocation. Annu Rev Biochem;76:243-265.
24. Petosa C., Collier R.J., Klimpel K.R., Leppla S.H., Liddington R.C. (1997) Crystal structure of the anthrax toxin protective antigen. Nature;385:833-838.
25. Lacy D.B., Wigelsworth D.J., Melnyk R.A., Harrison S.C., Collier R.J. (2004) Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci U S A;101:13147-13151.
26. Santelli E., Bankston L.A., Leppla S.H., Liddlington R.C. (2004) Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature;430:905-908. (PDB ID 1T6B).
27. Benson E.I., Huynh P.D., Finkelstein A., Collier R.J. (1998) Identification of residues lining the anthrax protective antigen channel. Biochem;37:3941-3948.
28. Nassi S., Collier R.J., Finkelstein A. (2002) PA63 channel of anthrax toxin: an extended b-barrel. Biochem;41:1445-1450.
29. Mogridge J., Mourez M., Collier R.J. (2001) Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. J Bacteriol;183:2111-2116.
30. Lauri G., Barlett P.A. (1994) CAVEAT: a program to facilitate the design of organic molecules. J Comp Aided Mol Design;8:51-66.
31. Kutzki O., Park H.S., Ernst J.T., Orner B.P., Yin H., Hamilton A.D. (2002) Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry. J Am Chem Soc;124:11838-11839.
32. Yin H., Lee G.I., Sedey K.A., Kutzki O., Park H.S., Omer B.P., Ernst J.T., Wang H.G., Sebti S.M., Hamilton A.D. (2005) Terphenyl-based bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-X-L. J Am Chem Soc;127:10191-10196.
33. Yin H., Lee G.I., Park H.S., Payne G.A., Rodriguez J.M., Sebti S.M., Hamilton A.D. (2005) Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction. Angew Chem Int Ed Eng;44:2704-2707.
34. Bergman N.H., Passalacqua K.D., Gaspard R., Shetron-Rama L.M., Quackenbush J., Hanna P.C. (2005) Murine macrophage transcriptional responses to Bacillus anthracis infection. Infect Immun;73:1069-1080.
35. Nard A., Papini E., Mocka M., Montecucco C. (1996) The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors. Biochem J;320:687-691.
36. Lin C., Kao Y., Liu W., Huang H., Chen K., Wang T., Lin H. (1996) Cytotoxic effects of anthrax lethal toxin on macrophage-like cell line J774A. Curr Microbiol;33:224-227.
37. Tang G., Leppla S.H. (1999) Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect Immun;67:3055-3060.
38. Gaddis B.D., Avranova L.V., Chmielewski J. (2007) Inhibitors of anthrax lethal factor. Bioorg Med Chem Lett;16:4575-4578.
39. Gaddis B.D., Rubert Pérez C.M., Chmielewski J. (2008) Inhibitors of anthrax lethal factor based upon N-oleyldopamine. Bioorg Med Chem Lett;18:2647-2470.